You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 16, 2025

Drug Price Trends for ULTRA LUBRICANT EYE DROPS


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for ULTRA LUBRICANT EYE DROPS

Average Pharmacy Cost for ULTRA LUBRICANT EYE DROPS

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ULTRA LUBRICANT EYE DROPS 70000-0457-01 0.34762 ML 2024-12-18
ULTRA LUBRICANT EYE DROPS 70000-0457-01 0.35982 ML 2024-11-20
ULTRA LUBRICANT EYE DROPS 70000-0457-01 0.33543 ML 2024-10-23
ULTRA LUBRICANT EYE DROPS 70000-0457-01 0.36120 ML 2024-09-18
ULTRA LUBRICANT EYE DROPS 70000-0457-01 0.36130 ML 2024-08-21
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Ultra Lubricant Eye Drops

Global Market Outlook for Ophthalmic Eye Drops

The global market for ophthalmic eye drops, including lubricant eye drops like Systane Ultra, is experiencing significant growth driven by several key factors.

Increasing Prevalence of Ophthalmic Disorders

The rise in prevalence of eye disorders such as dry eye syndrome, glaucoma, cataracts, and allergies is a major driver for the ophthalmic eye drop market. This trend is expected to continue, with the global ophthalmic eye drop market projected to grow from $17,271.8 million in 2024 to $25,876.4 million by 2034, at a CAGR of 4.7%[3].

Demographic Changes

The growing global elderly population is another significant factor. By 2050, the global elderly population is expected to reach around 2 billion, up from 617 million in 2015. This demographic shift is likely to boost the demand for ophthalmic eye drops, including lubricant eye drops[4].

Market Segmentation and Trends

Type of Eye Drops

The market is segmented into various types, including antibiotics, hormones, artificial tears, and others. The artificial tear segment, which includes products like Systane Ultra, accounted for the highest revenue in recent years and is expected to continue this trend. This is due to the increasing demand for products treating dry eye syndrome[1].

Regional Analysis

North America currently holds the highest market share for eye drops and lubricants, driven by the high prevalence of ophthalmic disorders such as glaucoma and cataracts. However, the Asia-Pacific region is emerging as a lucrative market due to rapid development in healthcare infrastructure and increasing healthcare initiatives by governments[1].

Price Analysis for Systane Ultra

Current Pricing

Systane Ultra, a popular lubricant eye drop, is priced around $18 for an 8-milliliter supply, depending on the pharmacy. Generic versions are also available, with prices starting from $11.51 for 15 milliliters[2].

Discounts and Patient Assistance Programs

Consumers can benefit from various discounts, coupons, copay cards, and patient assistance programs. For example, the Drugs.com Discount Card can save up to 80% on prescription medicines, including ophthalmic eye drops. Additionally, signing up for a MyAlcon account can provide access to free trial offers, coupons, and more for Systane products[2].

Price Projections

Market Growth Impact on Pricing

As the demand for ophthalmic eye drops increases, driven by the growing prevalence of eye disorders and demographic changes, the prices of these products may stabilize or slightly increase. However, the presence of generic versions and various discount programs is likely to keep prices competitive.

Competitive Landscape

The market is highly competitive, with key players such as Allergan, Alcon Laboratories, Inc., and Bausch Health US LLC. These companies often engage in strategic collaborations, partnerships, and continuous product launches, which can influence pricing strategies and keep prices in check[3].

Key Takeaways

  • Market Growth: The global ophthalmic eye drop market, including lubricant eye drops, is projected to grow significantly due to increasing prevalence of eye disorders and demographic changes.
  • Pricing: Current prices for Systane Ultra are around $18 for an 8-milliliter supply, with generic options available at lower prices.
  • Discounts and Assistance: Various discounts, coupons, and patient assistance programs are available to reduce the cost of ophthalmic eye drops.
  • Competitive Landscape: The market is competitive, with key players focusing on innovation and strategic partnerships, which helps maintain competitive pricing.

FAQs

What is the current market size for ophthalmic eye drops?

The global ophthalmic eye drop market was valued at $16,390.6 million in 2023 and is expected to reach $17,271.8 million in 2024[3].

What is the projected growth rate for the ophthalmic eye drop market?

The market is projected to grow at a CAGR of 4.7% from 2024 to 2034[3].

What are the main drivers for the growth of the ophthalmic eye drop market?

The main drivers include the increasing prevalence of eye disorders, growing global elderly population, and advancements in healthcare infrastructure[1][3][4].

How much does Systane Ultra typically cost?

Systane Ultra typically costs around $18 for an 8-milliliter supply, but prices can vary depending on the pharmacy and availability of discounts[2].

Are there any discounts or patient assistance programs available for Systane Ultra?

Yes, there are various discounts, coupons, copay cards, and patient assistance programs available to reduce the cost of Systane Ultra[2].

Which regions are expected to see significant growth in the ophthalmic eye drop market?

North America currently holds the highest market share, but the Asia-Pacific region is expected to emerge as a lucrative market due to rapid healthcare development and increasing healthcare initiatives[1].

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.